Verus Capital Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$476K Sell
16,949
-5,465
-24% -$145K 0.03% 270
2025
Q4
$558K Buy
22,414
+3,558
+19% +$89.7K 0.04% 245
2025
Q3
$480K Buy
18,856
+6,330
+51% +$156K 0.04% 244
2025
Q2
$304K Sell
12,526
-1,439
-10% -$33.6K 0.03% 290
2025
Q1
$354K Sell
13,965
-982
-7% -$25.7K 0.04% 258
2024
Q4
$397K Sell
14,947
-1,195
-7% -$32.4K 0.04% 236
2024
Q3
$469K Sell
16,142
-1,185
-7% -$34.6K 0.05% 201
2024
Q2
$485K Buy
17,327
+1,308
+8% +$36K 0.05% 194
2024
Q1
$445K Buy
16,019
+106
+0.7% +$2.94K 0.05% 207
2023
Q4
$458K Buy
15,913
+1,373
+9% +$41.5K 0.06% 184
2023
Q3
$482K Sell
14,540
-2,171
-13% -$76.8K 0.07% 165
2023
Q2
$613K Buy
16,711
+1,388
+9% +$54K 0.09% 138
2023
Q1
$625K Sell
15,323
-960
-6% -$41.5K 0.1% 129
2022
Q4
$834K Sell
16,283
-524
-3% -$25.1K 0.16% 95
2022
Q3
$736K Buy
16,807
+6,127
+57% +$298K 0.14% 105
2022
Q2
$920K Sell
10,680
-7,718
-42% -$393K 0.18% 98
2022
Q1
$912K Buy
+18,398
New +$955K 0.14% 108
2020
Q1
$633K Buy
20,439
+1,274
+7% +$43.4K 0.2% 70
2019
Q4
$712K Buy
+19,165
New +$683K 0.23% 72

Other funds holding PFE

Verus Capital Partners's PFE Position: Q1 2026 in Review

Verus Capital Partners reduced its Pfizer (PFE) stake by 24% in Q1 2026, selling an estimated $145K and leaving 16,949 shares worth $476K. The position accounts for 0.03% of the portfolio, ranked #270.

Verus Capital Partners first reported a position in PFE in Q4 2019 and has held it in 19 quarters since. The position peaked at $920K in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Verus Capital Partners held 16,949 shares of Pfizer worth $476K as of Q1 2026.
  • Verus Capital Partners sold 5,465 Pfizer shares in Q1 2026, an estimated $145K.
  • Pfizer made up 0.03% of Verus Capital Partners's portfolio in Q1 2026, its #270 holding.
  • Verus Capital Partners first reported a position in Pfizer in Q4 2019 and has held it in 19 quarters since.
  • Verus Capital Partners's Pfizer position peaked at $920K in Q2 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.